相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment
Kurt D. Christensen et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2020)
Research Use of Ecological Momentary Assessment for Adverse Event Monitoring Following Amyloid-β Results Disclosure
Meghan K. Mattos et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Added value of amyloid PET in individualized risk predictions for MCI patients
Ingrid S. van Maurik et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2019)
Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review
Arno de Wilde et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment
Jennifer H. Lingler et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
Keith A. Johnson et al.
ALZHEIMERS & DEMENTIA (2013)
Disclosure of amyloid imaging results to research participants: Has the time come?
Jennifer H. Lingler et al.
ALZHEIMERS & DEMENTIA (2013)
Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education
Keith A. Johnson et al.
Alzheimers & Dementia (2013)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (vol 11, pg 669, 2012)
C. M. Clark et al.
LANCET NEUROLOGY (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
Christopher M. Clark et al.
LANCET NEUROLOGY (2012)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
A New Scale Measuring Psychologic Impact of Genetic Susceptibility Testing for Alzheimer Disease
Winston W. Chung et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2009)
A validity and reliability study of the coping self-efficacy scale
Margaret A. Chesney et al.
BRITISH JOURNAL OF HEALTH PSYCHOLOGY (2006)
The revised Illness Perception Questionnaire (IPQ-R)
R Moss-Morris et al.
PSYCHOLOGY & HEALTH (2002)